Document is current
Any future updates will be listed below
-
Authors
Zhang, Zhen
Rafei-Shamsabadi, David
Lehr, Saskia
Buettner, Nico
Diehl, Rebecca
Huzly, Daniela
Pinato, David J
Thimme, Robert
Meiss, Frank
Bengsch, Bertram https://orcid.org/0000-0003-2552-740X
-
Funding
Funding for this research was provided by:
DFG (256073931, 441891347, 413517907, 378189018)
Universitätsklinikum Freiburg
- License Information
-
More Information
Article History
Received: 6 October 2022
Accepted: 4 November 2022
First Online: 12 December 2022
Declarations
:
: Study participants were recruited with approval of the Institutional Review Boards and biomaterials were collected after informed consent (Ethics committee of the Albert-Ludwigs-University, Freiburg, #474/14 & #22/1074). The study was performed in agreement with the principles expressed in the Declaration of Helsinki (2013).
: Not applicable.
: FM served as consultant and/or has received honoraria from Novartis, Roche, BMS, MSD, Pierre Fabre, Sanofi Genzyme and travel support from Novartis, Sunpharma and BMS. DRS served as consultant and/or has received honoraria from Roche and BMS and travel support from Sunpharma and Sanofi. DJP received lecture fees from ViiV Healthcare, Bayer Healthcare, BMS, Roche, IPSEN, EISAI, Falk Foundation, travel expenses from BMS and Bayer Healthcare; consulting fees for Mina Therapeutics, EISAI, Roche, Mursla, DaVolterra and Astra Zeneca; research funding (to institution) from MSD, GSK and BMS with no relation to the submitted work.
